Brian Nicholas Harvey
CIK: 0001519432
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Adicet Bio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 25, 2026ACET
Adicet Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
43.4K shares- - Jan 24, 2026ACET
Adicet Bio, Inc.
Tax Payment(F)Direct546 shares at avg. $8.44$5K - Jan 31, 2025ACET
Adicet Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
324K shares- - Jan 24, 2025ACET
Adicet Bio, Inc.
Tax Payment(F)Direct8.8K shares at avg. $0.92$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 25, 2026 | ACET Adicet Bio, Inc. | Award(A) Stock Option (Right to Buy) | 43,361 | - | - | Direct |
| Jan 24, 2026 | ACET Adicet Bio, Inc. | Tax Payment(F) | 546 | $8.44 | $4,608 | Direct |
| Jan 31, 2025 | ACET Adicet Bio, Inc. | Award(A) Stock Option (Right to Buy) | 324,040 | - | - | Direct |
| Jan 24, 2025 | ACET Adicet Bio, Inc. | Tax Payment(F) | 8,752 | $0.92 | $8,068 | Direct |
1-4 of 4 transactions
About Harvey Brian Nicholas
Harvey Brian Nicholas (SEC CIK 0001519432) files insider reports with the SEC as Chief Financial Officer of Adicet Bio, Inc. (ACET).
Signal8 holds 4 ownership filings by Harvey Brian Nicholas, all Form 4s, filed between Jan 28, 2025 and Mar 27, 2026. Those filings report 4 transactions, from Jan 24, 2025 to Mar 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Harvey Brian Nicholas's filings is in BOSTON, MA.
Recent filings by Harvey Brian Nicholas
Other insiders filing for Adicet Bio, Inc. (ACET)
- Klickstein Lloyd, Chief Medical Officer
- Schor Chen, President & CEO
- Aftab Blake, Chief Scientific Officer
- DUBIN STEVE, Director
- Chodakewitz Jeffrey, Director
- Grissinger Michael, Director